Word

INTRABIO

Status

Dead

Status Code

602

Status Date

Thursday, January 10, 2019

Serial Number

79232153

Mark Type

4000

Filing Date

Wednesday, February 14, 2018

Abandoned Date

Monday, December 17, 2018

Trademark Owner History

IntraBio Ltd

Classifications

5 Pharmaceutical preparations; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; drugs for medical purposes; drugs for medical purposes, namely, the prevention and treatment of neurodegenerative diseases; drugs for medical purposes, namely, the prevention and treatment of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; reagents for use in medical genetic testing; diagnostic reagents for medical laboratory use; diagnostic reagents for medical laboratory use, namely, use in the detection and identification of neurodegenerative diseases; diagnostic reagents for medical laboratory use, namely, use in the detection and identification of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; amino acid preparations for medical purposes; amino acid preparations for pharmaceutical use

42 Scientific and technological services and research and design relating thereto; industrial analysis and research services; scientific and technological services and research in the field of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; industrial analysis and research services related to neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy, design and development of computer hardware and software related to assays; clinical trials; conducting clinical trials for pharmaceutical products; conducting clinical trials for neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; medical laboratories for research related to neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; providing information about the results of clinical trials for pharmaceutical products; clinical research; medical laboratories; research relating to molecular sciences; medical research; genetic research; research in the field of gene therapy; biopharmaceutical research for development of targeted therapies for use in the treatment of carcinomas and neurodegenerative diseases; scientific, biochemical, research and development services in the field of neurodegenerative diseases; providing scientific information in the field of medical disorders and their treatment; pharmaceutical drug development services

Trademark Events

Jan 31, 2020

Final Decision Transaction Processed By Ib

Jan 10, 2020

Final Disposition Notice Sent To Ib

Jan 10, 2020

Final Disposition Notice Created, To Be Sent To Ib

Nov 8, 2019

Notification Of Possible Opposition - Processed By Ib

Oct 23, 2019

Notification Of Possible Opposition Sent To Ib

Oct 23, 2019

Notification Of Possible Opposition Created, To Be Sent To Ib

Jan 11, 2019

Abandonment Notice Mailed - Failure To Respond

Jan 10, 2019

Abandonment - Failure To Respond Or Late Response

Jun 30, 2018

Refusal Processed By Ib

Jun 14, 2018

Non-Final Action Mailed - Refusal Sent To Ib

Jun 14, 2018

Refusal Processed By Mpu

Jun 7, 2018

Non-Final Action (Ib Refusal) Prepared For Review

Jun 6, 2018

Non-Final Action Written

May 30, 2018

Assigned To Examiner

May 25, 2018

Application Filing Receipt Mailed

May 21, 2018

New Application Office Supplied Data Entered In Tram

May 17, 2018

Sn Assigned For Sect 66a Appl From Ib